Pharmaceutical Product Development Inc PPDI Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Nanoen Tek, Inc. (Symbol:039860) SWOT Analysis, Strategy, Revenues and Profits

Nanoen Tek, Inc. (Symbol:039860) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Nanoen Tek, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug Discovery and Development | Countries: South Korea, United States

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. JCL Bioassay Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug Discovery and Development | Countries: United States, Japan

MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary MEI Pharma, Inc. (MEI) is an oncology company. The company provides clinical development of therapeutics for the treatment of cancer. It develops cancer therapeutic with the help of naturally occurring compound Isoflavones. The company has developed two vaccine for the treatment of cancer ME-143 ...

Industries: Drug Discovery and Development | Countries: United States

DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary DATATRAK International, Inc. (DATATRAK) is a healthcare information technology company. The company provides e-clinical solutions and related services for the clinical trials industry. Its products include uCTMS, uDesign, uEDC, uIRT, uSafety, uTrain and uCDR. The company offers products to design, ...

Industries: Drug Discovery and Development | Countries: United States

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates

  • $ 264
  • Industry report
  • by La Merie Publishing
  • January 2015
  • 25 pages

Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the development pipeline of novel therapeutics for treatment of NASH. Purchase of ...

Industries: Drug Discovery and Development | Countries: United States, Japan

Pancreatic Endocrine Tumor - Pipeline Review, H2 2014

Pancreatic Endocrine Tumor - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 61 pages

Pancreatic Endocrine Tumor - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Pancreatic Endocrine Tumor - Pipeline Review, H2 2014', provides an overview of the Pancreatic Endocrine Tumor's therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Drug Discovery and Development | Countries: World, United States

Sjogren%s Syndrome - Pipeline Review, H2 2014

Sjogren%s Syndrome - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • December 2014
  • 55 pages

Sjogren's Syndrome - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Sjogren's Syndrome - Pipeline Review, H2 2014', provides an overview of the Sjogren's Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sjogren's Syndrome, ...

Industries: Drug Discovery and Development | Countries: World, United States

Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014

Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • December 2014
  • 62 pages

Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Trichomonas Vaginitis Global Clinical Trials Review, H2, 2014" provides data on the Trichomonas Vaginitis clinical trial scenario. This report provides elemental information and data relating ...

Industries: Drug Discovery and Development | Countries: World, United States

Pleural Effusion Global Clinical Trials Review, H2, 2014

Pleural Effusion Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • December 2014
  • 69 pages

Pleural Effusion Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pleural Effusion Global Clinical Trials Review, H2, 2014" provides data on the Pleural Effusion clinical trial scenario. This report provides elemental information and data relating to the clinical ...

Industries: Drug Discovery and Development | Countries: World, United States

Fanconi Anemia Global Clinical Trials Review, H2, 2014

Fanconi Anemia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • December 2014
  • 72 pages

Fanconi Anemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2014" provides data on the Fanconi Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials ...

Industries: Drug Discovery and Development | Countries: World, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.